Life ScienceCompany
Merrimack Pharmaceuticals M&A Summary
Merrimack Pharmaceuticals has acquired 1 company. It has also divested 1 asset.
It’s largest disclosed sale occurred in 2017, when it sold Merrimack Pharmaceuticals - Oncology Assets to Ipsen SA for $575M. Merrimack Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Merrimack Pharmaceuticals Business Overview
Where is Merrimack Pharmaceuticals headquartered?
Merrimack Pharmaceuticals is headquartered in Cambridge, Massachusetts.
What sector is Merrimack Pharmaceuticals in?
Merrimack Pharmaceuticals is a life science company.
When was Merrimack Pharmaceuticals founded?
Merrimack Pharmaceuticals was founded in 1993.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1